Atea PharmaceuticalsI Total Assets Over Time
| AVIR Stock | USD 3.70 0.01 0.27% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Atea PharmaceuticalsI Performance and Atea PharmaceuticalsI Correlation. Atea |
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.63) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.12) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Assets Analysis
Compare Atea PharmaceuticalsInc and related stocks such as Alkermes Plc, Ironwood Pharmaceuticals, and Deciphera Pharmaceuticals Total Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALKS | 55.7 M | 1.4 B | 1.5 B | 1.6 B | 1.9 B | 1.9 B | 1.7 B | 1.8 B | 1.8 B | 1.8 B | 1.9 B | 2 B | 2 B | 2.1 B | 2.2 B |
| IRWD | 135.9 M | 209 M | 229.9 M | 279 M | 333.5 M | 619.1 M | 709.8 M | 605.7 M | 332.1 M | 402.7 M | 559.2 M | 1.1 B | 1.1 B | 471.1 M | 499.5 M |
| DCPH | 26.8 M | 26.8 M | 26.8 M | 26.8 M | 26.8 M | 26.8 M | 58.9 M | 199.1 M | 315.6 M | 622.4 M | 642.4 M | 429.5 M | 454 M | 473.6 M | 393.8 M |
| PCRX | 50.5 M | 113.5 M | 112.1 M | 169.8 M | 326.1 M | 389.6 M | 391.5 M | 628.4 M | 689.4 M | 831.1 M | 1.3 B | 2.1 B | 1.7 B | 1.6 B | 1.7 B |
| COLL | 9 M | 9 M | 9 M | 9 M | 5.1 M | 97.7 M | 162 M | 135.6 M | 291.2 M | 306.3 M | 643.8 M | 692.1 M | 1.2 B | 1.1 B | 1.2 B |
| EGRX | 9.4 M | 9.4 M | 9.4 M | 18.1 M | 53.4 M | 124.6 M | 213.6 M | 270.1 M | 238.6 M | 254.6 M | 253.2 M | 253.7 M | 406.2 M | 467.1 M | 490.4 M |
| NBIX | 78 M | 138.4 M | 196 M | 154.7 M | 243 M | 474.8 M | 365.1 M | 817.6 M | 993.2 M | 1.3 B | 1.7 B | 2.1 B | 2.4 B | 3.3 B | 3.4 B |
| DVAX | 29.6 M | 134.1 M | 139.8 M | 204.6 M | 138.3 M | 216.6 M | 109.7 M | 218.8 M | 210.9 M | 279.1 M | 353.3 M | 1 B | 985.9 M | 997.1 M | 1 B |
| AMPH | 317.5 M | 317.5 M | 317.5 M | 338.7 M | 389.4 M | 390.1 M | 427.7 M | 454.7 M | 513.6 M | 587 M | 631.2 M | 671.5 M | 742 M | 1.5 B | 1.6 B |
Atea PharmaceuticalsInc and related stocks such as Alkermes Plc, Ironwood Pharmaceuticals, and Deciphera Pharmaceuticals Total Assets description
Total assets refers to the total amount of Atea PharmaceuticalsI assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Atea PharmaceuticalsInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Atea PharmaceuticalsInc | AVIR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.7
Check out Atea PharmaceuticalsI Performance and Atea PharmaceuticalsI Correlation. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Atea PharmaceuticalsI technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.